Connor, Clark & Lunn Investment Management Ltd. - PUMA BIOTECHNOLOGY INC ownership

PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 129 filers reported holding PUMA BIOTECHNOLOGY INC in Q2 2020. The put-call ratio across all filers is 2.10 and the average weighting 0.0%.

Quarter-by-quarter ownership
Connor, Clark & Lunn Investment Management Ltd. ownership history of PUMA BIOTECHNOLOGY INC
ValueSharesWeighting
Q3 2023$525,387
-25.5%
199,7670.0%0.00%
-25.0%
Q2 2023$705,178
+24.1%
199,767
+8.6%
0.00%
+33.3%
Q1 2023$568,390
-26.7%
183,945
+0.4%
0.00%
-25.0%
Q4 2022$775,232
+119.0%
183,270
+22.8%
0.00%
+100.0%
Q3 2022$354,000
+60.2%
149,294
+92.4%
0.00%
+100.0%
Q2 2022$221,000
-15.3%
77,591
-14.5%
0.00%0.0%
Q1 2022$261,000
-14.4%
90,731
-9.5%
0.00%0.0%
Q4 2021$305,000
+214.4%
100,215
+773.9%
0.00%0.0%
Q1 2020$97,000
-63.1%
11,467
+192.2%
0.00%
-50.0%
Q3 2016$263,000
-67.0%
3,925
-85.3%
0.00%
-66.7%
Q2 2016$796,000
-0.5%
26,725
-1.9%
0.01%0.0%
Q1 2016$800,000
-65.2%
27,250
-7.2%
0.01%
-68.4%
Q4 2015$2,301,000
-14.9%
29,350
-18.2%
0.02%
-13.6%
Q3 2015$2,704,000
-34.9%
35,875
+0.8%
0.02%
-42.1%
Q2 2015$4,156,000
-49.7%
35,600
+1.7%
0.04%
-45.7%
Q1 2015$8,264,000
+108.9%
35,000
+67.5%
0.07%
+118.8%
Q4 2014$3,956,000
+92.8%
20,900
+143.0%
0.03%
+88.2%
Q3 2014$2,052,0008,6000.02%
Other shareholders
PUMA BIOTECHNOLOGY INC shareholders Q2 2020
NameSharesValueWeighting ↓
Cormorant Asset Management, LP 200,000$20,706,0006.01%
Redmile Group, LLC 230,673$23,882,0002.95%
WEATHERBIE CAPITAL, LLC 241,419$24,994,0002.31%
Tekla Capital Management LLC 185,820$19,238,0002.02%
Ghost Tree Capital, LLC 25,000$2,588,0001.59%
ADAGE CAPITAL PARTNERS GP, L.L.C. 5,686,668$588,741,0001.56%
Iguana Healthcare Management, LLC 25,000$2,588,0001.48%
Eventide Asset Management 42,100$4,359,0001.34%
Bain Capital Public Equity Management, LLC 401,330$41,550,0001.17%
Rock Springs Capital Management LP 31,500$3,261,0001.16%
View complete list of PUMA BIOTECHNOLOGY INC shareholders